+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

Biologics Market Report 2025-2035 - Product Thumbnail Image

Biologics Market Report 2025-2035

  • Report
  • March 2025
  • 367 Pages
  • Global
From
From
From
From
From
From
mRNA Vaccines in Infectious Diseases Market Overview - Product Thumbnail Image

mRNA Vaccines in Infectious Diseases Market Overview

  • Report
  • December 2023
  • 76 Pages
  • Global
From
Liposomal Drug Delivery Devices Market Report 2026 - Product Thumbnail Image

Liposomal Drug Delivery Devices Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Global Antimicrobial Therapeutics Market 2026-2030 - Product Thumbnail Image

Global Antimicrobial Therapeutics Market 2026-2030

  • Report
  • September 2026
  • 309 Pages
  • Global
From
From
COVID-19 Clinical Trials Market - Global Forecast 2026-2032 - Product Thumbnail Image

COVID-19 Clinical Trials Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
From
From
From
Loading Indicator